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Histone H4 Is a Major Component of the
Antimicrobial Action of Human Sebocytes
Dong-Youn Lee1,4, Chun-Ming Huang1, Teruaki Nakatsuji1, Diane Thiboutot2,
Sun-Ah Kang3, Marc Monestier3 and Richard L. Gallo1
Antimicrobial peptides, such as cathelicidin and b defensins, directly kill microbes and have been detected in
human sebaceous glands and cell lines. Despite the presence of several such peptides, the apparent abundance
of these is insufficient for direct killing of most skin pathogens. In this study, we sought to determine which
molecules provide the majority of antimicrobial peptide activity in human sebocytes. Acid-soluble protein
extracts of SEB-1 sebocytes were separated by reverse-phase high-performance liquid chromatography and
were assayed for their capacity to inhibit the growth of Staphylococcus aureus. Antimicrobial activity was
isolated in a single major fraction and identified to be histone H4 by mass spectrometry and western blot
analysis. The importance of histone H4 in the antimicrobial activity of sebocytes was confirmed by a specific
neutralizing antibody and by direct demonstration that recombinant histone H4 had antimicrobial activity
against S. aureus and Propionibacterium acnes. In addition, histone H4 enhanced the antimicrobial action of
free fatty acids in human sebum. Taken together, these results indicate that the release of histone H4 by
holocrine secretion from the sebaceous gland may play an important role in innate immunity.
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INTRODUCTION
Antimicrobial peptides are crucial components of the innate
immune system that protects against microbial infection
(Zasloff, 2002). In part, acting as natural antibiotics,
antimicrobial peptides have a distinct and overlapping
antimicrobial activity against a variety of microbial pathogens
(Bals, 2000; Nagaoka et al., 2000). They are produced
constitutively or can be induced in a variety of types,
including phagocytes and epithelial cells (Gallo et al., 1994;
Ganz, 2002), and they can directly kill a broad spectrum of
bacteria, fungi, and viruses. Their role is particularly
important in the skin where they play an important role in
first-line defense against infection (Izadpanah and Gallo,
2005). In the keratinocyte, cathelicidins and b defensins are
major families of antimicrobial peptides (Frohm et al., 1997;
Ali et al., 2001). In addition, however, many other peptides
and proteins in the skin also show antimicrobial activity,
including proteinase inhibitors, chemokines, and neuropep-
tides (Braff et al., 2005).
The sebaceous gland is a major appendage and exocrine
gland in the skin consisting of specialized epithelial cells
named sebocytes (Thody and Shuster, 1989; Thiboutot,
2004). Human sebaceous glands are distributed in all areas
of the skin except in that of the palms and soles. Although the
sebaceous gland produces and secretes lipid-rich sebum onto
the external skin surface by the holocrine rupture of mature
sebocytes, the fundamental functions of this gland have been
only partly understood (Zouboulis, 2003). These functions
include the hypothesis that the sebocyte provides an innate
immune defensive function. This has been supported by
observations that antimicrobial peptides are produced by
these cells. For example, human b defensins (HBD)-1 and -2
were found in human pilosebaceous units by in situ
hybridization and immunohistochemistry (Chronnell et al.,
2001). An HBD-2 mRNA expression was induced in SZ95
sebocytes by Propionibacterium acnes (P. acnes), a predo-
minant organism in pilosebaceous units (Nagy et al., 2006).
Psoriasin (S100A7) has been detected in sebaceous glands by
immunohistochemistry (Glaser et al., 2005). Recently, we
reported that human sebocytes express cathelicidin antimi-
crobial peptides and can act to kill P. acnes (Lee et al., 2008).
Moreover, sebaceous lipids exhibit antibacterial activity
(Wille and Kydonieus, 2003; Georgel et al., 2005). These
findings suggested that the human sebaceous gland may play
an important role in the innate immunity of the skin through
the expression of antimicrobial peptides and specific lipids.
However, the measured concentration of the previously
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defined antimicrobial peptides in the extracts of sebocytes
was lower than the concentration necessary for antimicrobial
activity. Thus, although multiple antimicrobial peptides have
been detected in sebocytes, it remains unclear which are
functionally important to immune defense. Here, we carried
out an unbiased functional screening of proteins derived from
sebocytes for antimicrobial activity. On the basis of this
screening, we identified histone H4 as the predominant
peptide active against Staphylococcus aureus (S. aureus) and
P. acnes.
RESULTS
Purification of antimicrobial activity from cultured human
sebocytes
To identify antimicrobial molecules produced by the sebac-
eous gland, SEB-1 sebocytes were subjected to a variety of
initial extraction methods including chloroform, detergent,
and aqueous extraction techniques. Only acid extracts,
predominantly representing the acid-soluble protein fraction
of the cell, were antimicrobial in the solution-killing assay
against S. aureus DmprF, a well-defined S. aureus strain
selected for its sensitivity to cationic antimicrobial peptides.
These extracts were subsequently separated by reverse-phase
high-performance liquid chromatography (RP-HPLC)
(Figure 1a) and by the bactericidal activity of the HPLC
fractions examined against S. aureus by limiting dilution. In
this screening, only a single fraction (fraction 13) was
confirmed to have an antibacterial activity (Figure 1b).
Identification of Histone H4 as an antimicrobial peptide
As predicted by the initial HPLC tracing, each of the fractions
separated from sebocyte extracts contained multiple protein
bands (Figure 1c). On the basis of the findings of the
antimicrobial activity and the SDS-PAGE, one band migrating
at approximately 11 kDa in the active fraction was found to
be interesting. To identify this molecule, tryptic peptide
digests were analyzed by Nano liquid chromatography-mass
spectrometry (MS). Histones, H2A, H2B, and H4, were
identified with H4 being most abundant (Table 1).
To confirm these results, each of the HPLC fractions was
evaluated by western blot with an anti-histone antibody
(BWA-3). BWA-3 is a monoclonal antibody that reacts with a
common sequence in the amino-terminus of histones H2A
and H4 (Monestier et al., 1993). In fraction 13, one strong
band was seen at 11 kDa, which corresponded to the
expected size of histone H4 (Figure 2a) and to the unique
protein predicted to have antimicrobial activity in Figure 1c.
In fraction 12, one strong band was observed at 13 kDa,
which corresponded to the expected size of histone H2A
(Figure 2a). An additional western blot analysis with a
different antibody that specifically reacts with acetyl histone
H4 confirmed that the band in fraction 13 is H4 (Figure 2b).
Evaluation of the total acid-soluble extracts of SEB-1 by
western blot with the anti-histone antibody (BWA-3) further
confirmed the presence of the two histone bands at 11 and
13 kDa, corresponding to histones H4 and H2A (Figure 2c).
Histone H4 was much more abundant than histone H2A
in the total extract. A similar result was obtained in the
acid-soluble fraction of the SEB-1 debris released into the
culture medium, also showing two bands, with the majority
being histone H4 (Figure 2c). To further confirm histone H4
expression in human sebaceous glands, histological sections
of normal human scalp tissue were examined for histone H4
expression by immunohistochemistry with BWA-3. As
expected for this essential component of the chromosome,
histone H4 was detected in the nuclei of the sebocytes and in
those of all other cells within the biopsy (data not shown).
Thus, on the basis of the results of functional HPLC analysis,
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Figure 1. Purification of the antimicrobial activity from extracts of cultured sebocytes. (a) RP-HPLC was carried out to separate antimicrobial peptides from
acid-soluble extracts of SEB-1 sebocytes. A plot of absorbance at 214 nm is indicated on the left y axis and that of the concentration of acetonitrile used for
elution on the right y axis. (b) The antimicrobial activity of the HPLC fractions was evaluated against S. aureus DmprF by solution-killing assay. Growth of
bacterial colonies on agar after incubation with fractions obtained by RP-HPLC separation is shown with limiting dilutions from top to bottom. A single fraction
(fraction 13) showed maximal antimicrobial activity. (c) HPLC fractions were subjected to SDS-PAGE and stained with Coomassie’s blue. Arrow in the active
fraction indicates a unique protein band that was further analyzed by mass spectrometry.
2490 Journal of Investigative Dermatology (2009), Volume 129
D-Y Lee et al.
Histone H4 is an Antimicrobial of Sebocytes
Coomassie staining, mass spectrometry, and western blot
analysis, histone H4 was identified as a top candidate
responsible for the antimicrobial activity in fraction 13.
Histone H4 has direct antimicrobial activity against S. aureus
and P. acnes
To confirm whether histone H4 can kill bacteria found on the
skin, bactericidal assays were carried out using a purified
recombinant histone H4 protein against relevant skin patho-
gens such as S. aureus or P. acnes. Bacteria were incubated
for 3 hours at 371C in an assay buffer consisting of a 10mM
sodium phosphate buffer (pH 6.5) and 100mM NaCl. Histone
H4 showed bactericidal activity against both S. aureus DmprF
(25 mgml1) and P. acnes (12.5 mgml1) in a dose-dependent
manner compared with the control (Figure 3). Furthermore,
as histone H4 is released from sebocytes along with lipids,
which are metabolized into free fatty acids with antimicrobial
activity, the combined antimicrobial activity of histone H4 in
the presence of free fatty acids was examined. Lauric acid
and oleic acid at low concentrations (1.5mgml1) enhanced
the antimicrobial action of histone H4 (Figure 4). At higher
concentrations of fatty acids (60 mgml1), lauric acid
completely inhibited S. aureus survival at 12.5 mgml1
histone H4, but oleic acid at this concentration killed all of
the bacteria. Thus, as expected, free fatty acids present on the
skin are inherently antimicrobial, but will also enhance the
antimicrobial potency of peptides such as histone H4
released by the sebocyte.
Histone H4 is a major component of the antimicrobial activity
of sebocyte extracts
Having found that histone H4 is a possible antimicrobial
protein, we next sought to determine the relative contribution
of histone H4 to the functional antimicrobial activity
observed from sebocytes. The specific histone antibody
(BWA-3) described earlier (Kim et al., 2002) was used in a
functional assay in an attempt to block the activity of histones
H4 and H2A in the entire SEB-1 extract. The addition of
BWA-3 to the extracts of SEB-1 sebocytes significantly
inhibited antimicrobial activity against S. aureus DmprF as
seen by an approximately two logs better growth of bacteria
Table 1. Proteins identified by mass spectrometry
from sebocyte antimicrobial fraction
Identified
protein
Accession
no./database Peptide sequence
Sequence
coverage (%)
Histone H4 NP_778224.1/ ISGLIYEETR 63.1
NCBI TLYGFGG
DAVTYTEHAK
KTVTAMDVVYALK
TVTAMDVVYALK
VFLENVIR
RISGLIYEETR
DNIQGITKPAIR
DNIQGITK
DNIQGITKPAIRR
NP_003538.1/ ILGLIYEETRR 19.4
NCBI ILGLIYEETR
DNIQGITK
Histone H2B NP_778225.1/ AMGIMNSFVNDIFER 27
NCBI KESYSIYVYK
LLLPGELAK
NP_066407.1/ KESYSVYVYK 27
NCBI LLLPGELAK
AMGIMNSFVNDIFER
Histone H2A NP_002097.1/ ATIAGGGVIPHIHK 23.4
NCBI AGLQFPVGR
HLQLAIR
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Figure 2. Identification of histone H4 in antimicrobial fractions purified
from cultured sebocytes. (a) Western blot analysis with anti-histone antibody
(BWA3, specific for histones H2A and H4) was carried out on HPLC fractions
shown in Figure 1. In fraction 13, a single strong band was observed at
11 kDa, which corresponded to the expected mass of histone H4. In fraction
12, a single strong band was observed at 13 kDa, which corresponded to the
expected mass of histone H2A. The lane marked as H4 was loaded with
recombinant histone H4 used as a positive control. (b) Western blot analysis
with the specific anti-acetyl histone H4 antibody showed a single band at
11 kDa only in fraction 13. (c) Acid-soluble extracts of SEB-1 sebocytes and
the culture medium containing SEB-1 sebocyte debris was evaluated by
western blot with an anti-histone H2A and H4 antibody (BWA-3). Two bands
were observed at 11 and 13 kDa, which corresponded to histones H4 and
H2A. H4, recombinant histone H4, was used as a positive control.
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in the presence of a sebocyte extract plus BWA-3 compared
with that with a sebocyte extract plus IgG at a similar
concentration, or with PBS as controls (Figure 5). Thus, the
ability to neutralize the majority of the antimicrobial action of
sebocyte extracts with a specific antibody to histone H4
suggests that histone H4 is the major acid-soluble antimicro-
bial protein released by the sebocyte.
DISCUSSION
Many studies have shown that antimicrobial peptides are
essential elements of epithelial defense, providing a barrier
against infection of the skin and other epithelial organs
(Zasloff, 2002; Braff et al., 2005). Human sebaceous glands
may contribute to the defense of the skin through the release
of antimicrobial peptides (Chronnell et al., 2001; Glaser
et al., 2005, Lee et al., 2008). In this study, we examined
human sebocytes to identify functionally important antimi-
crobials in human sebaceous glands. In a non-biased
biochemical screening, histone H4 was found to be the
major antimicrobial protein in the extracts of SEB-1 sebo-
cytes. Recombinant histone H4 showed antimicrobial activity
against S. aureus and P. acnes, both potential pathogens of
the human pilosebaceous unit. Finally, by selective neutra-
lization of histone, this protein was found to have a major
role in the antimicrobial activity of sebocytes. These
observations suggest that histone H4 in the human sebaceous
gland can contribute to the innate immune defense of the
skin, providing an additional source of antimicrobial activity
that acts in the defense against infection.
To our knowledge, this is the first report showing that
histones can act as antimicrobial peptides on human skin.
Although histone proteins exist primarily in the nucleus and
are known for their involvement in chromatin formation and
in the regulation of transcription, there is precedence for the
conclusion that histones or histone-derived peptides can have
antimicrobial properties (Parseghian and Luhrs, 2006). Other
activities such as hormone-like activity and endotoxin-
neutralizing activity have also been reported for histones
S. aureus mprF
(CFU ml–1)
P. acnes
(CFU ml–1)
**
**
**
**
1.0E+07
1.0E+06
1.0E+05
1.0E+04
1.0E+03
1.0E+02
**
**
**
1.0E+07
1.0E+08
1.0E+06
1.0E+05
1.0E+04
1.0E+03
1.0E+02
100
Histone H4 (µg ml–1)
50 12.525 Control 100
Histone H4 (µg ml–1)
50 12.525 Control
Figure 3. Recombinant histone H4 kills S. aureus and P. acnes. The antimicrobial activity of recombinant histone H4 was evaluated against S. aureus DmprF
and P. acnes by the solution-killing assay. Bacteria were incubated for 3 hours at 371C in a 10mM sodium phosphate buffer (pH 6.5) containing 100mM NaCl.
Recombinant histone H4 showed significant bactericidal activity against S. aureus DmprF at 25 mgml1 and above and against P. acnes at 12.5mgml1 and
above. Data shown are from triplicate determinations (**Po0.01; Student’s t-test).
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Figure 4. Recombinant histone H4 enhances the antimicrobial action of free fatty acids. The antimicrobial activity of histone H4 was evaluated in the presence
of free fatty acids. Lauric and oleic acids (1.5 mgml1) synergistically exerted antimicrobial effects in combination with histone H4. Lauric acid (60mgml1)
exerted a stronger synergy with histone H4, but oleic acid at this concentration killed all bacteria. Data shown are from triplicate determinations (*Po0.05;
Student’s t-test). DMSO, dimethyl sulfoxide: LA, lauric acid: OA, oleic acid.
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(Reichhart et al., 1985; Kim et al., 2002). In humans, histone
H1, derived from epithelial cells in the gastrointestinal tract,
is active against Salmonella typhimurium (Rose et al., 1998).
The histones, H2A and H2B, are secreted into the amniotic
fluid from epithelial cells on the surface of the human
placenta and they participate in host defenses of the fetus
(Kim et al., 2002). Recently, neutrophil extracellular traps
containing histones in human neutrophils were identified as a
novel antimicrobial mechanism (Brinkmann et al., 2004). In
this study, the antimicrobial action of histone is particularly
relevant in the setting of the sebaceous gland function, as
these cells secrete their contents into the sebum by
disintegration of the entire cell, a process known as holocrine
secretion. Thus, it is particularly relevant for sebocytes to use
histones as a part of their antimicrobial system. The current
data detecting antimicrobial activity for histone H4 in the
extracts of human sebocyte cultures, and in the culture
medium from these cells, support the conclusion that histone
H4 from human sebaceous glands in vivo is released with
sebum onto the surface of the skin, and once released can act
as an antimicrobial.
As major components of the nucleosome structure in
eukaryotic cells, the histones are functionally classified into
two groups: linker histones (H1), which seal loops of DNA
and keep the nucleosome structures condensed in compact
conformations, and core histones (H2A, H2B, H3, and H4),
which form an octameric complex to produce the nucleo-
some. Most earlier studies have shown that the lysine-rich
histones (H1, H2A, and H2B) and their fragments have
antimicrobial activity (Hiemstra et al., 1993; Rose et al.,
1998; Kim et al., 2002; Howell et al., 2003). There have been
only a few reports on the antimicrobial activities of histone
H4. A mixture of histones H2B and H4 obtained from
hemocytes of Pacific shrimp showed an activity against
Gram-positive bacteria (Patat et al., 2004). In human
meconium, the histones H2A and H4 have been isolated
and identified by their antimicrobial activity (Kai-Larsen
et al., 2007). Recently, the post-translationally modified
histone H4 was purified from the skin extract of a Japanese
tree frog, but the protein did not show any antimicrobial
activity (Kawasaki et al., 2008). Histone H4, as well as H2A,
H2B, and H3, have shown bacterial LPS-binding abilities
(Augusto et al., 2003). In addition, as mentioned earlier, the
neutrophil extracellular traps have been observed to react
with antibodies against the histones, H1, H2A, H2B, H3, and
H4, and may be a part of their antimicrobial function
(Brinkmann et al., 2004). In this study, we showed by
solution-killing assay that histone H4 contributes to the
antimicrobial activity of the extracts of SEB-1 sebocytes, and
that this occurs in physiologically relevant ionic conditions
and against relevant microbes such as S. aureus and P. acnes.
To detect histones in HPLC fractions and in the extracts of
sebocytes, we used a monoclonal anti-histone antibody
(BWA-3). BWA-3 reacts with peptides l–20 of histone H2A
and l–29 of histone H4 (Monestier et al., 1993). This antibody
was previously also used as a neutralizing antibody (Kim
et al., 2002). As a result, it was relevant to test the addition of
this antibody as a neutralizing antibody to the extracts of SEB-
1 sebocytes, and results show that this significantly decreased
the antimicrobial activity. Although the neutralizing antibody
blocked both histones H2A and H4, the extracts of the
sebocytes had a higher histone H4 content than a histone
H2A content, and antimicrobial activity was not detected in
HPLC fractions that contained abundant histone H2A but not
histone H4. These results suggested that the antimicrobial
activity in the extracts of sebocytes was likely because of
histone H4 and not because of histone H2A.
Several antimicrobial peptides are found in sebocytes and
may work with histone H4 to increase antimicrobial activity.
Earlier, human b defensins-1 and -2 were described in human
pilosebaceous units, including the sebaceous glands (Chron-
nell et al., 2001). Psoriasin (S100A7) was found in human
sebaceous glands (Glaser et al., 2005) and our lab has
recently shown that cathelicidin antimicrobial peptides are
present in cultured human sebocytes and glands (Lee et al.,
2008). On the basis of the results of the neutralization of
antimicrobial activity with an anti-histone H4 antibody, our
data suggest that histone H4 probably plays a larger role as a
direct antimicrobial substance than do the other antimicro-
bial peptides previously identified in the sebocyte. This
conclusion is consistent with the approximate concentration
of these antimicrobial peptides compared with their potency
to kill bacteria. However, the actual concentration of histone
H4 and other antimicrobial peptides released by human
sebaceous glands remains unknown. Nevertheless, on the
basis of the known additive or synergistic activity of
antimicrobial peptides (Nagaoka et al., 2000), it is likely that
these factors work together to provide an immune defense.
In addition to antimicrobial peptides in the human
sebaceous gland, sebaceous lipids have been shown to
exhibit an innate antimicrobial activity (Georgel et al., 2005;
Clarke et al., 2007). In the sebum, oleic acid predominates,
and lauric acid is one of the strongest antimicrobial lipids
against Gram-positive bacteria, although it is a minor free
fatty acid (Wille and Kydonieus, 2003; Bodoprost and
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Figure 5. Neutralization of histone H4 in sebocyte extracts removes
antimicrobial activity. BWA-3 neutralizing antibody was used to treat extracts
of SEB-1 sebocytes. Addition of BWA-3 (400 mgml1) to the extracts of SEB-1
sebocytes significantly decreased antimicrobial activity against S. aureus
DmprF compared with an equal concentration of IgG added to separate
aliquots, or aliquots to which an equal volume of PBS was added as controls.
Data shown are from triplicate determinations (*Po0.05; Student’s t-test).
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Rosemeyer, 2007). Thus, we chose these free fatty acids for
combined effects with histone H4. Histone H4 showed
synergistic antimicrobial effects with free fatty acids against
S. aureus. These findings suggest that the production of lipids
by the sebaceous gland, and the metabolism to antimicrobial
free fatty acids by resident microbes, may further contribute
to epithelial defense by combining activity with histone H4
and the antimicrobial peptides. However, an alternative
explanation for the role of histone H4 in the sebaceous gland
is that it may serve a more specialized and focused role in the
protection of the gland itself against infection. In this study,
histone H4 was shown to kill P. acnes, a normal microflora in
the pilosebaceous unit. Therefore, sebaceous antimicrobial
peptides and lipids may act only under special circum-
stances, such as microbial proliferation in the follicle.
Taken together, our data suggest that histone H4 is a
functionally important antimicrobial peptide released by the
holocrine secretion mechanism of human sebocytes. Further,
in vivo studies of the surface expression of histones on human
skin, and mechanistic studies to determine how histone H4
acts as an antimicrobial peptide, are required to fully
elucidate their role in skin defense.
MATERIALS AND METHODS
Culture of SEB-1 human sebocytes
The immortalized human sebaceous gland cell (sebocyte) line, SEB-
1, was grown in a culture medium consisting of DMEM with 5.5mM
glucose/Ham’s F-12 3:1, fetal bovine serum 2.5%, adenine
1.8 104M, hydrocortisone 0.4mgml1, insulin 10 ngml1, epi-
dermal growth factor 3 ngml1, and cholera toxin 1.2 1010M at
371C in a humidified atmosphere containing 5% CO2 in air
(Thiboutot et al., 2003).
Extraction of acid-soluble proteins from SEB-1 sebocytes
SEB-1 sebocytes were cultured to confluence in 75 cm2 culture
flasks. After washing with PBS, SEB-1 sebocytes were extracted in
1M HCl-1% trifluoroacetic acid. The extracts of the SEB-1 sebocytes
in the acid were centrifuged at 12,000 r.p.m., and the supernatant
was collected. The supernatant was then frozen and lyophilized. In
addition, the debris of the SEB-1 sebocytes in the culture medium
was centrifuged and extracted in the same way as the extraction of
the SEB-1 sebocytes.
Separation of antimicrobial peptides
Antimicrobial peptides were separated from the acid extracts of the
SEB-1 sebocytes by a previously described method with slight
modifications (Murakami et al., 2004). The lyophilized material of
the acid-soluble protein extracts of the SEB-1 sebocytes was
dissolved in 10% acetonitrile-0.1% trifluoroacetic acid. Peptide
separation was carried out using an AKTA purification system
(Amersham Pharmacia Biotech, Piscataway, NJ) on a Sephasil
peptide C18 column (12 mm, ST 4.6/250; Amersham Pharmacia
Biotech). The acid-soluble protein extracts of the SEB-1 sebocytes
were separated by reverse-phase high-performance liquid chroma-
tography (RP-HPLC) after column equilibration in 0.1% trifluoroa-
cetic acid at a flow rate of 2mlmin1. Elution was carried out using
gradients of 0–25% and 25–60% acetonitrile for 5 or 25minutes. The
column effluent was monitored at 214, 230, and 280 nm.
All collected fractions (1.5ml) were frozen and lyophilized, and
then resuspended in distilled water for antimicrobial assay and
immunoassay. The protein concentration was determined using a
bicinchoninic acid protein assay (Pierce, Rockford, IL), with BSA as a
standard.
Antimicrobial activity assay of HPLC fractions
For screening the antimicrobial activity of the HPLC fractions, a
solution-killing assay was carried out as described earlier (Lee et al.,
2008). Lyophilized HPLC fractions were resuspended in 30 ml of
distilled water and were then tested against S. aureus DmprF (a gift
from A. Peschel, Microbial Genetics, University of Tubingen,
Tubingen, Germany). This strain of S. aureus was selected for
screening because of its increased sensitivity to cationic peptides.
S. aureus DmprF was grown in a tryptic soy broth and collected in
the log phase. The number of S. aureus DmprF was enumerated by
applying a conversion factor (2.0 108 bacteria per ml¼ 0.6 OD
unit at 600 nm). The bacteria (CFU) were suspended in a 10mM
sodium phosphate buffer (pH 6.5) supplemented with 100mM NaCl,
and 5ml of HPLC fractions were added and incubated at 371C for 3 h.
After incubation, 10-fold dilutions were prepared and plated
on tryptic soy broth agar and the plates were incubated for 1 day
at 371C.
SDS-PAGE
The HPLC fractions were analyzed for the content of proteins/
peptides by SDS-PAGE. An equal volume of HPLC fractions was
prepared by mixing with a sample buffer, and was then denatured
at 951C for 5minutes. Electrophoresis was carried out on 16%
Tris-tricine gels (NuSep, Austell, GA) with running buffer for 2 hours
at 100V. To visualize the protein/peptide bands, the gel was
stained with Coomassie solution according to the manufacturer’s
instructions.
Mass spectrometry analysis
For protein identification, one band of interest in the active fraction
was cut out of the Coomassie stained gel and enzymatically digested
with trypsin (0.2 mg, 25mM Tris, 4M urea, pH 7.8) at 371C overnight.
Tryptic peptide digests were analyzed by Nano liquid chromato-
graphy-mass spectrometry as described earlier (Nakatsuji et al.,
2008). The automated Nano liquid chromatography-mass spectro-
metry setup consisted of an Agilent 1200 Nano 2D LC system, a
switch valve, a C18 trap column (Agilent, Santa Clara, CA), and a
capillary reverse-phased column (10 cm in length, 75 mm i.d.)
packed with 5 mm C18 AQUASIL resin with an integral spray tip
(Picofrit, 15 mm tip, New Objective, Woburn, MA). A reverse-phase
LC, directly linked to a Bruker Daltonics HCTultra PTM system mass
spectrometer (Bruker Daltoniks, Bremen, Germany), was carried out
using a linear gradient elution from buffer A (H2O plus 0.1% formic
acid) to 50% buffer A plus 50% buffer B (acetonitrile plus 0.1%
formic acid) in 100minutes. The setup was operated in the data-
dependent mode. Data on the four strongest ions above an intensity
of 2 105 were collected with dynamic exclusion enabled, and the
collision energy was set at 35%. The MS/MS spectra were extracted
using a default value by BioTools 3.1 (Bruker Daltoniks). All MS/MS
spectra were analyzed using in-house Mascot 2.1 server (Matrix
Science, London, UK) for protein identification. Mascot was
established to search the human database (downloaded from the
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NCBI website http://www.ncbi.nlm.nih.gov/) containing protein
sequences in both forward and reverse orientations using trypsin as
a digestion enzyme.
Western blot analysis
The fractions separated by HPLC were evaluated by western blot
analysis. First, SDS-PAGE was carried out as described above and then
transferred onto a polyvinylidene difluoride membrane (Immobilon-P;
Millipore, Danvers, MA). For a positive control, the recombinant
histone H4 peptide (Biolabs, New England) was used. The membrane
was treated with a blocking solution for 30minutes at room
temperature, and then a mouse monoclonal anti-histone antibody
(BWA-3) (10mgml1 in blocking solution) or a rabbit polyclonal anti-
acetyl histone H4 antibody (Cell Signaling, Danvers, MA) was
incubated with the membrane overnight at 41C. BWA-3 reacts with
histones, H2A and H4 (Monestier et al., 1993). After washing the
membrane three times with 0.1% TTBS, a horseradish peroxidase-
labeled goat anti-mouse polyclonal antibody (1:5,000 in the blocking
solution; DAKO, Carpinteria, CA) or a horseradish peroxidase-
labeled goat anti-rabbit polyclonal antibody was incubated with the
membrane for 60minutes at room temperature. After washing the
membrane with 0.1% TTBS, it was immersed in an ECL solution
(Western Lightning Chemiluminescence Reagents Plus; Perkin-Elmer
Life Sciences, Boston, MA) for 60 seconds, and was then exposed to
an X-ray film (X-Omat; Eastman Kodak, Rochester, NY). In addition,
acid-soluble extracts of the SEB-1 sebocytes, and of the debris of the
SEB-1 sebocytes in the culture medium, were evaluated by western
blot analysis with an anti-histone antibody (BWA-3).
Antimicrobial activity assays
To evaluate the antimicrobial activity of the recombinant histone,
H4, solution-killing assay was performed. Recombinant histone H4
peptide (Biolabs), which was dissolved in the PBS buffer, was tested
against S. aureus DmprF and P. acnes. The bacteria were exposed to
a range of recombinant histone H4 peptide concentrations
(100mgml1, 50 mgml1, 25 mgml1, and 12.5 mgml1) at 371C for
3 hours. The same PBS buffer was used as a negative control. S.
aureus DmprF was grown as described above. The P. acnes strain,
ATCC6919 (American Type Cell Culture, Manassas, Virginia), was
grown under anaerobic conditions in Reinforced Clostridial Medium
(Oxoid, Basingstroke, England) for 2 days and collected in the log
phase. The number of P. acnes was enumerated by applying a
conversion factor (P. acnes 5 108 bacteria per ml¼ 1.0 OD unit at
600 nm). After incubation, 10-fold dilutions were prepared and
plated on solid media comprised of Brucella broth (BD Biosciences,
San Diego, California) with 5% sheep red blood cells (Remel,
Lenexa, Kansas), 0.5mg l1 vitamin K, and 5.0mg l1 hemin
(Remel). The plates were incubated for 4 days at 371C under
anaerobic conditions, and then individual colonies were counted.
The killing efficiency of the recombinant histone H4 peptide was
plotted using CFU per ml1 after peptide incubation versus peptide
concentrations, representing the survivor cells and the toxic potency
of the histone H4 peptide against S. aureus DmprF and P. acnes.
To explore the contribution of the histone H4 to the antimicrobial
activity of the acid-soluble protein extracts of the SEB-1 sebocytes,
the lyophilized extracts of the SEB-1 sebocytes were resuspended in
PBS. The extracts of the SEB-1 sebocytes were combined in triplicate
with a monoclonal mouse anti-histone antibody (BWA-3)
(400mgml1) or with the same concentration of control IgG or
PBS for 2 hours at room temperature and analyzed for antimicrobial
activity against S. aureus DmprF using the solution-killing assay.
To evaluate the combined antimicrobial activity of histone H4
with free fatty acids, a solution-killing assay was carried out. Two
free fatty acids (Sigma, St. Louis, MO), which were dissolved in
dimethyl sulfoxide (DMSO), were tested against S. aureus DmprF.
The bacteria were exposed to a range of recombinant histone H4
peptide concentrations (50 mgml1, 25 mgml1, and 12.5mgml1) in
the PBS buffer in the presence of lauric or oleic acid (1.5 mgml1 and
60 mgml1) at 371C for 3 hours. DMSO [5% (v v1)] was used as a
negative control. After incubation, 10-fold dilutions were prepared
and plated on tryptic soy broth agar, and the plates were incubated
for 1 day at 371C.
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